Mark For: TRANSCEND THE LAB™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88178527 |
Mark Literal Elements | TRANSCEND THE LAB |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED 2020-02-27 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Paul K. Tomita |
Attorney Docket Number | ECL.08 |
Law Office Assigned | N50 |
Employee Name | REID, CAILE MAUREEN |
2018-11-01 | Application Filed |
2019-08-01 | Location: TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED |
2019-08-01 | Status: Live/Pending |
2019-08-01 | Transaction Date |
2020-02-27 | Location: TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED |
2020-02-27 | Status: Abandoned due to incomplete response. The response did not satisfy all issues in the Office action. To view all documents in thi |
Party: | Emerald Cloud Lab, Inc. |
Address | 844 Dubuque Ave. South San Francisco, CALIFORNIA UNITED STATES 94080 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | JPEG | 2018-11-01 |
TEAS RF New Application | MULTI | 2018-11-01 |
Offc Action Outgoing | MULTI | 2019-01-28 |
XSearch Search Summary | XML | 2019-01-28 |
Response to Office Action | APPLICATION/XML | 2019-07-25 |
Amendment and Mail Process Complete | MULTI | 2019-07-27 |
Offc Action Outgoing | MULTI | 2019-08-01 |
TEAS Request Reconsideration after FOA | MULTI | 2020-02-03 |
Amendment and Mail Process Complete | MULTI | 2020-02-05 |
Offc Action Outgoing | XML | 2020-02-27 |
Notice of Abandonment | APPLICATION/XML | 2020-02-28 |
(ABANDONED)
IC 042. US 100 101. G & S: Software as a service (SaaS) featuring software for designing laboratory experiments, for running laboratory experiments, and for reviewing laboratory experiment controls, equipment, and environmental data; software as a service (SaaS) featuring software for reviewing laboratory experiment results; software as a service (SaaS) featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines; software as a service (SaaS) featuring software for scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; software as a service (SaaS) featuring software for biopharmaceutical research design and scientific testing services; software as a service (SaaS) featuring software for product safety testing for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; software as a service (SaaS) featuring software for toxicological safety testing services for pharmaceuticals, chemicals, and consumer products; software as a service (SaaS) featuring software for development of quality control assays for the safety, purity, and manufacturing processes for pharmaceuticals, chemicals, consumer products and custom designs; software as a service (SaaS) featuring software for remotely deploying quality control assays for the safety, purity, and manufacturing processes for pharmaceuticals, chemicals, consumer products, and custom designs; software as a service (SaaS) featuring software for remotely managing the performance of quality control assays for the safety, purity, and manufacturing processes for pharmaceuticals, chemicals, consumer products, and custom designs; software as a service (SaaS) featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; and software as a service (SaaS) featuring software for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Software as a service featuring software for designing laboratory experiments, for running laboratory experiments, and for reviewing laboratory experiment controls, equipment, and environmental data ; software as a service featuring software for reviewing laboratory experiment results; software as a service featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines; software as a service featuring software for scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; software as a service featuring software for biopharmaceutical research design and scientific testing services; software as a service featuring software for product safety testing for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; software as a service featuring software for toxicological safety testing services for pharmaceuticals, chemicals, and consumer products; software as a service for developing quality control and custom assays; software as a service for remotely deploying quality control and custom assays; software as a service for remotely managing the performance of quality control and custom assays; software as a service featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; and software as a service for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE | 2020-02-28 | |
ABANDONMENT - INCOMPLETE RESPONSE | 2020-02-27 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-04 | 88889 |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2020-02-03 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-03 | 88889 |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2019-08-01 | |
FINAL REFUSAL WRITTEN | 2019-08-01 | 93416 |
FINAL REFUSAL E-MAILED | 2019-08-01 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-07-26 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-07-25 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-07-25 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-01-28 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-01-28 | 93416 |
NON-FINAL ACTION E-MAILED | 2019-01-28 | 6325 |
ASSIGNED TO EXAMINER | 2019-01-22 | 93416 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-11-17 | |
NEW APPLICATION ENTERED IN TRAM | 2018-11-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.